![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Yourgene Obtains CE Mark for Prenatal Genetic-Disorder Test
Yourgene Obtains CE Mark for Prenatal Genetic-Disorder Test
Yourgene has earned the CE mark for its Illumina-based molecular diagnostic for Down’s syndrome and other genetic disorders.
The nucleic acid screening test, IONA Nx, assesses the likelihood that a pregnant woman’s fetus has Down’s syndrome, Edwards syndrome or Patau syndrome.
The laboratory-based test is run on the company’s NextSeq 550Dx sequencing platform. Yourgene said it expects to launch the test in the coming months.
Upcoming Events
-
21Oct